PMC:7795856 / 3158-3359 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"129","span":{"begin":182,"end":185},"obj":"Species"},{"id":"133","span":{"begin":161,"end":180},"obj":"Disease"}],"attributes":[{"id":"A129","pred":"tao:has_database_id","subj":"129","obj":"Tax:10407"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"MESH:D019694"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tide drug has been marketed for more than 20 years under the trade name Zadaxin™ in more than 30 countries. Zadaxin™ is clinically approved for the treatment of chronic hepatitis B (HBV), chronic hepat"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T7","span":{"begin":161,"end":178},"obj":"Phenotype"}],"attributes":[{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0200123"}],"text":"tide drug has been marketed for more than 20 years under the trade name Zadaxin™ in more than 30 countries. Zadaxin™ is clinically approved for the treatment of chronic hepatitis B (HBV), chronic hepat"}